On January 27, 2020, Avivagen Inc. (TSXV:VIV) closed the transaction. The company issued 3,500,000 units for CAD 1,650,000 in its second and final tranche. All the securities issued in the second tranche as subject to hold period ending May 28, 2020. The company paid CAD 94,620 and issued 189,240 finders warrant as finders’ fees pursuant to the second tranche. The company paid a total of CAD 194,620 as finders’ fees in the transaction. Each finders warrant entitles the holder to purchase one unit at CAD 0.50 per unit for a period of 2 years. On February 6, 2020, the company announced that TSX Venture Exchange has accepted filing documentation pursuant to the transaction. The transaction involved participation from 87 placees, including insider, including Shane McLean for 9,500 units, Kym Anthony of Top Meadow Consulting Services Inc. for 100,000 units, and 18 aggregate pro-group placees for 1,310,000 units.